Importantly, reducing EZH2 levels can slow tumor growth and enhance the effectiveness of anti-cancer drugs, making EZH2 inhibition a promising strategy in the fight against lung cancer (Gong et al., 2020). This evidence concerns the gene EZH2 and lung carcinoma.